September 22, 2010
Blood Thinner OK for Superficial Leg Clots:
A blood-thinning drug
could help some patients with superficial-vein thrombosis avoid
more serious blood clots, a new study suggests. But experts
question whether the benefit is worth the drug's high price.
Consumer Activists Want Modified Salmon to Be
Opponents of genetically
modified salmon, as well as consumer activists and
environmentalists, told a U.S. Food and Drug Administration
advisory panel Tuesday that it would be irresponsible not to
require labels on the fish if it is approved for humans to eat.
FDA Approves 1st Oral Drug to Reduce MS
The U.S. Food and Drug
Administration on Wednesday approved the first oral drug to reduce
relapses of multiple sclerosis, the nervous system disorder that
has traditionally been treated with injectable drugs.
Gilenya Approved for Relapsing MS
Gilenya (fingolimod) has
been approved by the U.S. Food and Drug Administration to reduce
relapses and delay disability progression in people with relapsing
forms of multiple sclerosis.